Genmab A/S (GMAB)

Genmab Revenue

In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 41.10% growth.

• Revenue (ttm): $3.72B
• Revenue Growth: +26.19%
• P/S Ratio: 4.80
• Revenue / Employee: $1,251,261
• Employees: 2,973
• Market Cap: 17.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.72B	599.00M	19.19%
Dec 31, 2024	3.12B	731.00M	30.59%
Dec 31, 2023	2.39B	302.26M	14.48%
Dec 31, 2022	2.09B	800.56M	62.19%
Dec 31, 2021	1.29B	-372.56M	-22.45%
Dec 31, 2020	1.66B	854.42M	106.10%
Dec 31, 2019	805.32M	340.75M	73.35%
Dec 31, 2018	464.57M	83.44M	21.89%
Dec 31, 2017	381.13M	123.38M	47.87%
Dec 31, 2016	257.75M	92.65M	56.12%
Dec 31, 2015	165.10M	26.80M	19.38%
Dec 31, 2014	138.30M	15.94M	13.02%
Dec 31, 2013	122.37M	36.66M	42.77%
Dec 31, 2012	85.70M	24.59M	40.23%
Dec 31, 2011	61.12M	-43.27M	-41.45%
Dec 31, 2010	104.39M	-8.77M	-7.75%
Dec 31, 2009	113.16M	-16.25M	-12.56%
Dec 31, 2008	129.42M	25.30M	24.29%
Dec 31, 2007	104.12M	80.20M	335.29%
Dec 31, 2006	23.92M	8.33M	53.41%
Dec 31, 2005	15.59M	-	-